Our latest network meta-analysis looking at efficacy of behavioural therapies in #IBS is now published online in @LancetGastroHep sciencedirect.com/science/arti...

New research - Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis www.thelancet.com/journals/lan... #GastroSky #MedSky @alexanderford25.bsky.social @romegastropsych.bsky.social

New @lancetgastrohep.bsky.social Non-inferiority of lyophilised faecal filtrate vs lyophilised donor stool was not established for the prevention of C difficile recurrence over 8 weeks 👉 Live 🦠 crucial in mediating clinical efficacy www.thelancet.com/journals/lan... #GISky #IDSky #MicroSky #FMT

Medical students often view IBS as “less real” and harder to treat than IBD, biases that deepen with training. Since physician perceptions shape care, we must intervene early with education that frames IBS as legitimate and models compassionate, evidence-based care.

Our July 2025 issue is out now at www.thelancet.com/gastrohep! The issue includes content on alcohol and health, eosinophilic oesophagitis, hepatocellular carcinoma, pancreatic cancer, viral hepatitis, and much more... #gastrosky #oncsky #idsky #medsky

Our latest issue is out now! 👇👇👇 #gastrosky #medsky #oncsky #hepsky

Obituary for Rob Sapsford (1964-2024): Leeds cardiologist whose breadth of knowledge and sense of humour have left a huge hole. Sapsford's warmth meant his office became an unofficial break room as colleagues would often pop in for a chat www.bmj.com/content/389/...

For patients with eosinophilic oesophagitis, etrasimod 2 mg once-daily treatment resulted in a significantly greater percentage decrease from baseline in oesophageal PEC versus placebo #gastrosky #medsky

What is the best diet for IBS? www.medscape.com/viewarticle/... via @medscape.com #gastrosky #medsky @alexanderford25.bsky.social

New online! Common misconceptions and controversies in the management of irritable bowel syndrome

New @lancetchildadol.bsky.social - Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain—not otherwise specified, and abdominal migraine in children www.thelancet.com/journals/lan... #IBSAwarenessMonth #GastroSky #MedSky #IBS #WorldIBSDay

New Editorial - Breaking the cycle: time to invest in IBS www.thelancet.com/journals/lan... #WorldIBSDay #IBSAwarenessMonth #IBS #IrritableBowelSyndrome #GastroSky #MedSky

Breaking the cycle: time to invest in IBS - The Lancet Gastroenterology & Hepatology www.thelancet.com/journals/lan...

New research - Cuffe et al - Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis www.thelancet.com/journals/lan... #WorldIBSDay #IBSAwarenessMonth #GastroSky #MedSky #IBS #IrritableBowelSyndrome

New research - Khasanaweh et al - Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis www.thelancet.com/journals/lan... #WorldIBSDay #IBSAwarenessMonth #IrritableBowelSyndrome #IBS #GastroSky #MedSky

Back to back papers from our group in @lancetgastrohep.bsky.social on #WorldIBSday 2025 Read them here: www.thelancet.com/journals/lan... www.thelancet.com/journals/lan...

On #WorldIBSDay2025 our updated meta-analysis of gut brain neuromodulators in #IBS is published in @lancetgastrohep.bsky.social www.thelancet.com/journals/lan...

On #WorldIBSDay2025 our updated network meta-analysis of dietary interventions in #IBS is published in @lancetgastrohep.bsky.social www.thelancet.com/journals/lan...

Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial gut.bmj.com/content/74/5... Latest paper from the @AtlantisTrial in this months edition of @Gut_BMJ

#DYK April is #IBSAwareness Month? We join the IBS community and caretakers to raise awareness about this GI condition. IBS affects all patients differently. Use our clinical guidance for recommendations to treat this common GI condition: gastro.org/news/ibs-cli....

A must-listen for anyone working with people with DGBI 👇🏼 Great summary and experience from Alex Ford podcasts.apple.com/au/podcast/t...

New collection on the clinical #microbiome from @naturemedicine.bsky.social @naturemicrobiol.bsky.social @naturecomms.bsky.social @commsmed.bsky.social open for submissions! More info on how to submit here www.nature.com/collections/... #Gastrosky #microsky 🧪

A masterclass review of the structure & function of the intestinal barrier, recent insights into the role of barrier function in chronic inflammatory & neoplastic diseases, plus novel concepts for treatment 👇👇👇 #GastroSky #MedSky #OncSky

New Review - Neurath, Artis, Becker - The intestinal barrier: a pivotal role in health, inflammation, and cancer www.thelancet.com/journals/lan... #GastroSky #MedSky

New research - Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study buff.ly/qFR1yau #LiverSky #MedSky

As #WashUAlum🐻, it's an incredible honor to give GI Grand Round as visiting professor at #WashU. Extra special to speak in the room named after Dr. Ray Clouse, who introduced me to the field when I was a med student & inspired me to become an investigator. Thank you for the wonderful day ❤️